Cargando…

Effect of roxadustat on intact and C-terminal FGF23 levels in patients undergoing peritoneal dialysis: a post hoc analysis of a randomized trial

Detalles Bibliográficos
Autores principales:	Wang, Zi, Xu, Xiao, Song, Di, Yang, Bin, Xu, Ying, Ma, Tiantian, Yang, Zhikai, Fu, Gang, Zhao, Jing, Dong, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539215/ https://www.ncbi.nlm.nih.gov/pubmed/37779854 http://dx.doi.org/10.1093/ckj/sfad084

Ejemplares similares

Randomized Study on the Efficacy of Standard Versus Low Roxadustat Dose for Anemia in Patients on Peritoneal Dialysis
por: Yang, Zhikai, et al.
Publicado: (2021)

Evaluating the effect of Roxadustat on ventricular repolarization in patients undergoing peritoneal dialysis
por: Zhang, Yangyang, et al.
Publicado: (2023)

Effects of Roxadustat on the Anemia and Iron Metabolism of Patients Undergoing Peritoneal Dialysis
por: Hirai, Keiji, et al.
Publicado: (2021)

Efficacy of roxadustat in treatment of peritoneal dialysis patients with renal anaemia
por: Zhu, Xin-Wang, et al.
Publicado: (2021)

Changes of biomarkers for erythropoiesis, iron metabolism, and FGF23 by supplementation with roxadustat in patients on hemodialysis
por: Yoshida, Shunsuke, et al.
Publicado: (2023)

Efficacy of Roxadustat on anemia and residual renal function in patients new to peritoneal dialysis
por: Wu, Tong, et al.
Publicado: (2022)

Effect of roxadustat on iron metabolism in patients with peritoneal dialysis: a real-world 24-week study
por: Zhang, Xuejie, et al.
Publicado: (2023)

Comparison of risk of peritoneal dialysis-associated peritonitis between roxadustat and recombinant human erythropoietin in peritoneal dialysis patients: a retrospective comparative cohort study
por: Zhang, Wei, et al.
Publicado: (2022)

C-terminal and intact FGF23 in kidney transplant recipients and their associations with overall graft survival
por: Chu, Chang, et al.
Publicado: (2021)

Short-term effects of roxadustat on serum copper and iron changes in a peritoneal dialysis patient
por: Nakamura, Hironori, et al.
Publicado: (2022)

Response to roxadustat in a patient undergoing long-term dialysis and allergic to erythropoiesis-stimulating agents: A case report
por: Xu, Cai, et al.
Publicado: (2022)

Comparison between the influence of roxadustat and recombinant human erythropoietin treatment on blood pressure and cardio-cerebrovascular complications in patients undergoing peritoneal dialysis
por: Cheng, Shuiqin, et al.
Publicado: (2023)

Longitudinal FGF23 and Klotho axis characterization in children treated with chronic peritoneal dialysis
por: Cano, Francisco J., et al.
Publicado: (2014)

Effect of ferric carboxymaltose on serum phosphate and C-terminal FGF23 levels in non-dialysis chronic kidney disease patients: post-hoc analysis of a prospective study
por: Prats, Merche, et al.
Publicado: (2013)

Roxadustat for CKD-related Anemia in Non-dialysis Patients
por: Coyne, Daniel W., et al.
Publicado: (2020)

The cut-off values of handgrip strength and lean mass index for sarcopenia among patients on peritoneal dialysis
por: Xu, Xiao, et al.
Publicado: (2020)

Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis
por: Provenzano, Robert, et al.
Publicado: (2020)

Operational considerations for peritoneal dialysis management during the COVID-19 pandemic
por: Yang, Zhikai, et al.
Publicado: (2020)

Dietary Potassium and Clinical Outcomes among Patients on Peritoneal Dialysis
por: Pan, Jinru, et al.
Publicado: (2023)

Phase 3 Study of Roxadustat to Treat Anemia in Non–Dialysis-Dependant CKD
por: Akizawa, Tadao, et al.
Publicado: (2021)

The open system of FGF-23 at the crossroad between additional P-lowering therapy, anemia and inflammation: how to deal with the intact and the C-terminal assays?
por: Magagnoli, Lorenza, et al.
Publicado: (2023)

Population pharmacokinetics of roxadustat in Japanese dialysis‐dependent chronic kidney disease patients with anaemia
por: Takada, Akitsugu, et al.
Publicado: (2021)

Intermittent Oral Dosing of Roxadustat in Peritoneal Dialysis Chronic Kidney Disease Patients with Anemia: A Randomized, Phase 3, Multicenter, Open‐Label Study
por: Akizawa, Tadao, et al.
Publicado: (2019)

Impact of Environmental Particulate Matter and Peritoneal Dialysis-related Infection in Patients Undergoing Peritoneal Dialysis
por: Huang, Wen-Hung, et al.
Publicado: (2014)

High dose intravenous iron, mineral homeostasis and intact FGF23 in normal and uremic rats
por: Gravesen, Eva, et al.
Publicado: (2013)

Levels of serum sclerostin, FGF-23, and intact parathyroid hormone in postmenopausal women treated with calcitriol
por: Cheng, Qun, et al.
Publicado: (2018)

Roxadustat: Not just for anemia
por: Zhu, Xiaoyu, et al.
Publicado: (2022)

Relationship between Residual Urine Output and Type of Dialysis with FGF23 Levels
por: Corradi, Valentina, et al.
Publicado: (2022)

Pregnancy in a woman undergoing peritoneal dialysis: Management and dialysis options
por: Veríssimo, Rita, et al.
Publicado: (2022)

The management of anemia in pediatric peritoneal dialysis patients: Guidelines by an ad hoc European committee
por: Schröder, Cornelis H.
Publicado: (2003)

Bacterial Peritonitis Caused by Tsukamurella inchonensis in a Patient Undergoing Continuous Ambulatory Peritoneal Dialysis
por: Tang, Ling, et al.
Publicado: (2022)

Lower Limb Ulcer Associated with Peritonitis in Patients Undergoing Peritoneal Dialysis
por: Terada, Kohsuke, et al.
Publicado: (2021)

Prevalence of chronic periodontitis in patients undergoing peritoneal dialysis and its correlation with peritoneal dialysis-related complications
por: Chen, Zhihao, et al.
Publicado: (2023)

Roxadustat in treating anemia in dialysis patients (ROAD): protocol and rationale of a multicenter prospective observational cohort study
por: Zhang, Yaling, et al.
Publicado: (2021)

The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients
por: Ye, Hongjian, et al.
Publicado: (2017)

Clinical performance of a new intact FGF23 immunoassay in healthy individuals and patients with chronic hypophosphatemia
por: Kato, Hajime, et al.
Publicado: (2023)

Predictors of intact and C-terminal fibroblast growth factor 23 in Gambian children
por: Braithwaite, Vickie, et al.
Publicado: (2013)

Fat tissue and inflammation in patients undergoing peritoneal dialysis
por: Rincón Bello, Abraham, et al.
Publicado: (2016)

Abrupt spontaneous suprachoroidal hemorrhage post-23-gauge vitrectomy during peritoneal dialysis
por: Kim, Moosang, et al.
Publicado: (2013)

Clinical Pharmacokinetics and Pharmacodynamics of Roxadustat
por: Czock, David, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fadk6nmk9snosb1ueiqdc237k1